Showing results (51-60 of 64) with videos related to
Sort By:
Pageof 7
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 24, 2025
The Involvement of PI3K-Akt Signaling in the Clinical and Pathological Findings of Idiopathic Multicentric Castleman Disease-Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis, and Organomegaly and Not Otherwise Specified SubtypesTomoka Haratake, Midori Filiz Nishimura, Asami Nishikori, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 3, 2023
[A Case of Malignant Peripheral Nerve Sheath Tumor of the Anus Resected by Robot Assisted-APR]Azusa Yamamoto, Takatoshi Matsuyama, Satoshi Hatano, et al.Plos One|March 31, 2016
Establishment of a Therapeutic Anti-Pan HLA-Class II Monoclonal Antibody That Directly Induces Lymphoma Cell Death via Large Pore FormationShuji Matsuoka, Yasuyuki Ishii, Atsuhito Nakao, et al.Leukemia & Lymphoma|September 8, 2017
Clinicopathologic investigation of methotrexate-induced lymphoproliferative disorders, with a focus on regressionMichihide Tokuhira, Shuntaro Saito, Ayumi Okuyama, et al.Journal of Clinical and Experimental Hematopathology : JCEH|October 27, 2024
Transcriptome analysis of the cytokine storm-related genes among the subtypes of idiopathic multicentric Castleman diseaseAsami Nishikori, Midori Filiz Nishimura, Shuta Tomida, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 26, 2026
The Complexity and Challenges of Translating the Dark Zone Signature into Immunohistochemistry in Diffuse Large B-Cell LymphomaShuji Momose, Keisuke Sawada, Theodora Nedeva, et al.Annals of Hematology|March 10, 2025
TP53 deletion is associated with poor survival of adult ALK-positive ALCL patients receiving CHOP-based chemotherapySeiichiro Katagiri, Daigo Akahane, Kunihiko Takeyama, et al.Journal of Clinical Pathology|February 20, 2024
Diagnostic challenges of the idiopathic plasmacytic lymphadenopathy (IPL) subtype of idiopathic multicentric Castleman disease (iMCD): Factors to differentiate from IgG4-related diseaseAsami Nishikori, Midori Filiz Nishimura, David C Fajgenbaum, et al.Haematologica|September 11, 2025
Distinct interleukin-6 production in IPL and TAFRO subtypes of idiopathic multicentric Castleman diseaseAsami Nishikori, Midori Filiz Nishimura, Yoshito Nishimura, et al.Blood|April 24, 2020
LUBAC accelerates B-cell lymphomagenesis by conferring resistance to genotoxic stress on B cellsTomoyasu Jo, Momoko Nishikori, Yasunori Kogure, et al.Pageof 7